isotonic_sheet
TL3 Regular · Brno, CZ
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 31 December 2024 · last posted 7d · groups: analytical-chemists
144 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions Replied, post #56 · Access › Shortages · 21 Jul 2026 · 16 likes I read the earlier replies on shortages twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
-
Splitting an overlong document into two Replied, post #33 · Documentation › Wiki requests · 18 Jul 2026 · 3 likes Whatever the answer on splitting an overlong document turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
-
Journal club: what we got wrong in an earlier session Replied, post #85 · Evidence › Journal club · 15 Jul 2026 · 14 likes Suggest the next paper at the end of the session rather than by message afterwards. The room has just worked out what it wants to know next. Two sources, same…
-
Why chargeback is not the safety net people assume Replied, post #24 · Sourcing › Payments · 11 Jul 2026 · 7 likes Where a supplier issues a quote with an expiry, honouring it after the expiry is a courtesy rather than an entitlement, and several here have found it granted.
-
I have no scientific background — can I still follow the analytics categories? Replied, post #32 · Start Here › Welcome · 3 Jul 2026 · 11 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
How shortages have affected compounding permissions Replied, post #12 · Access › Shortages · 3 Jul 2026 · 0 likes That is consistent with mine, for whatever one more account is worth.
-
Prescription requirements and telehealth models — a second dataset Replied, post #87 · Sourcing › Regulatory · 1 Jul 2026 · 22 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence. I would be glad to be…
-
Submitting a sample: the process end to end Replied, post #39 · Sourcing › Independent verification · 26 Jun 2026 · 4 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #44 · Compounds › Repair & healing peptides · 18 Jun 2026 · 19 likes This settles it for me, at least until somebody posts a reason it should not.
-
Racemisation and why it is invisible to a mass measurement Replied, post #36 · Analytics › Impurities & related substances · 10 Jun 2026 · 17 likes Incomplete deprotection leaves a protecting group attached, raising the mass substantially and usually pushing retention much later. A late-eluting peak on a peptide…
-
Naming conventions for research peptides and the confusion they cause Replied, post #13 · Compounds › Other compounds · 9 Jun 2026 · 3 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Reading a trial's population section before its results Replied, post #87 · Evidence › Trials · 4 Jun 2026 · 0 likes The arithmetic in post #85 is right; the assumption feeding it is the part to check. Trial duration determines what can be observed. A weight-change trajectory at 40…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #22 · Compounds › Secretagogues & GH axis · 3 Jun 2026 · 8 likes Worth separating secretagogues and glucose tolerance as a question about the compound from secretagogues and glucose tolerance as a question about the documentation.…
-
Historical amylin analogues and what happened to them Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 29 May 2026 · 0 likes Where the historical amylin analogues discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the…
-
Tracking intake honestly when appetite is absent Replied, post #39 · Nutrition & Training › Protein & intake · 28 May 2026 · 5 likes Adding the boring version of tracking intake, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
-
Spreadsheets: an appreciation — what changed since Replied, post #48 · Lounge › Off topic · 21 May 2026 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
An 18-month record including the parts that went badly Replied, post #20 · Outcomes › Progress reports · 20 May 2026 · 1 like Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions.
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #25 · Evidence › Trials · 12 May 2026 · 21 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #39 · Compounds › Tirzepatide · 10 May 2026 · 11 likes Where I would push back on the Tirzepatide and nausea consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #21 · Pharmacology › Formulation chemistry · 7 May 2026 · 0 likes Light sensitivity varies enormously between peptides depending on the residues present. Tryptophan-containing sequences are the ones where it matters most. The short…
-
Blind submission and why it changes minds — the long version Replied, post #57 · Sourcing › Independent verification · 5 May 2026 · 26 likes Post #53 describes the usual case. This is about the unusual one. The strongest argument against my own position on Blind submission, stated as well as I can state it,…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #8 · Analytics › COA interpretation · 28 Apr 2026 · 11 likes Taking post #5 at face value and following it one step further. A certificate is a statement by its issuer that a defined test was performed on a defined lot and…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #32 · Practice › Interactions · 25 Apr 2026 · 6 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #25 · Clinical › Bloodwork · 24 Apr 2026 · 0 likes Confirming post #24 from a second method, which matters more than confirming it from a second person. Glycaemic markers integrate over different periods. A point…
-
Coming back to: Time to steady state after a dose increase Replied, post #37 · Pharmacology › Pharmacokinetics · 21 Apr 2026 · 1 like Adding the measurement that post #36 says would settle it. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is…
-
Micro-titration: a disputed topic, argued properly Replied, post #62 · Practice › Dosing & titration · 19 Apr 2026 · 2 likes Post #61 is the version of this I will quote in future. One addition. Practical answer on micro-titration, since the theoretical one is upthread: do the simplest check…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #15 · Devices › Syringes & needles · 14 Apr 2026 · 7 likes Narrowing post #12, because the general version has more than one answer. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more…
-
Choosing which test to pay for, given a fixed budget Replied, post #65 · Sourcing › Independent verification · 11 Apr 2026 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. Noting that the question and the thing people…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #44 · Practice › Interactions · 9 Apr 2026 · 3 likes Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #55 · Data & Tools › Calculators · 29 Mar 2026 · 22 likes Post #52 put the caveat in the right place and I want to underline it. The question underneath titration planner refuses is usually "how would I tell?" rather than…
-
Grapefruit: why this class is not the class that cares Replied, post #89 · Practice › Interactions · 28 Mar 2026 · 27 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #20 · Meta › Announcements · 23 Mar 2026 · 0 likes Adding the measurement that post #19 says would settle it. The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #17 · Analytics › Impurities & related substances · 17 Mar 2026 · 0 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. Related substances: compounds chemically related to the target…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #51 · Start Here › Welcome · 9 Mar 2026 · 15 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #14 · Compounds › Repair & healing peptides · 8 Mar 2026 · 9 likes Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #149 · Sourcing › Independent verification · 5 Mar 2026 · 31 likes I would be cautious about generalising from the interpreting a result example above. It is a good example. It is one example.
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #99 · Evidence › Study critique · 1 Mar 2026 · 1 like Post #98 is right about the mechanism and I think understates the practical bit. Attrition is the failure mode most likely to invalidate a result and the least likely…
-
A single out-of-range value on an otherwise normal panel Replied, post #18 · Clinical › Bloodwork · 27 Feb 2026 · 5 likes Single out-of-range value is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone…
-
Choosing which test to pay for, given a fixed budget Replied, post #6 · Sourcing › Independent verification · 25 Feb 2026 · 4 likes Nothing to add, except that this is the answer I would give if asked.
-
Measurement error in a self-reported exposure Replied, post #67 · Evidence › Study critique · 25 Feb 2026 · 17 likes A note on how measurement error gets discussed rather than on measurement error itself: the confident posts get the replies and the careful ones get ignored, and the…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 20 Feb 2026 · 4 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #80 · Outcomes › Progress reports · 18 Feb 2026 · 0 likes The question underneath Seven-day rolling is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #13 · Compounds › Secretagogues & GH axis · 11 Feb 2026 · 0 likes For anyone finding this later: the short answer on Evidence quality is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #21 · Compounds › Semaglutide · 6 Feb 2026 · 32 likes Everything in post #19 holds. The case it does not cover is the one I have. On dose steps: the four-week interval in the pivotal programme was a trial design choice,…
-
Dead volume across syringe and needle combinations Replied, post #65 · Devices › Syringes & needles · 2 Feb 2026 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #31 · Practice › Storage & stability · 2 Feb 2026 · 2 likes On post #29 — agreed on the reasoning, with one qualification. My position on Adsorptive losses is current rather than settled. I have revised it once already and I…
-
Revisiting: Absolute versus relative contraindications Replied, post #16 · Safety › Contraindications · 30 Jan 2026 · 33 likes Post #14 describes the usual case. This is about the unusual one. Two things can be true about Absolute versus relative contraindications at once: the mechanism is…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #13 · Clinical › Comorbidities · 22 Jan 2026 · 8 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.
-
What a stability-indicating method is and how you demonstrate one Replied, post #4 · Analytics › Method validation · 19 Jan 2026 · 13 likes Good question, well framed, and I would like to see it answered properly.
-
MHRA statements, read directly Replied, post #70 · Regional › UK & Ireland · 17 Jan 2026 · 9 likes One more thing on MHRA statements that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Adolescents: a distinct evidence base — one year on Replied, post #54 · Clinical › Special populations · 15 Jan 2026 · 13 likes My understanding of Adolescents is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #7 · Outcomes › Body composition · 12 Jan 2026 · 6 likes Building on post #4 rather than restating it. I keep a log for Ultrasound and skinfolds specifically because my memory of it turned out to be systematically wrong in…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #49 · Pharmacology › Pharmacokinetics · 31 Dec 2025 · 27 likes Adding what did not work for me on Half-life, since the failures never get written up and they are half the useful information.
-
Early satiety becoming a problem rather than a benefit Replied, post #20 · Practice › Side effects · 29 Dec 2025 · 1 like Where I part company with post #18, and it is a narrow parting. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
-
Tracking that stops updating and then resumes Replied, post #61 · Sourcing › Logistics · 28 Dec 2025 · 0 likes Post #60 answers the question as asked. The question underneath it is different. Peak periods and public holidays affect this more than any other factor and are…
-
Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #4 · Compounds › Tirzepatide · 12 Dec 2025 · 13 likes Noted, and thank you for writing it out rather than summarising it.
-
Tracking that stops updating and then resumes — the long version Replied, post #43 · Sourcing › Logistics · 26 Nov 2025 · 11 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #55 · Compounds › Semaglutide · 26 Nov 2025 · 7 likes Building on post #52 rather than restating it. On the "does it stop working" question: tolerance in the pharmacological sense is not what the withdrawal trials show.…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #19 · Compounds › Oral incretins · 25 Nov 2025 · 1 like Building on post #16 rather than restating it. Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different…
-
Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common… Replied, post #4 · Practice › Storage & stability · 24 Nov 2025 · 10 likes Adding the measurement that the opening post says would settle it. A beyond-use date on a home preparation is an inference rather than a measurement. It can be a…
-
Thyroid function tests during substantial weight change Replied, post #147 · Clinical › Bloodwork · 24 Nov 2025 · 0 likes Post #145 put the caveat in the right place and I want to underline it. Liver enzyme changes during rapid weight loss are commonly reported and have several possible…
-
Pen dose counters: what a click does and does not guarantee Replied, post #95 · Devices › Pens & autoinjectors · 18 Nov 2025 · 0 likes Post #91 put the caveat in the right place and I want to underline it. Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming…
-
[2026 update] What steady state means for the decision to escalate Replied, post #87 · Practice › Dosing & titration · 14 Nov 2025 · 6 likes Where I part company with post #85, and it is a narrow parting. What I would tell a new member reading about steady state for the first time: the confident posts are…
-
About the Prescriber conversations category Replied, post #12 · Clinical › Prescriber conversations · 26 Oct 2025 · 2 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. Bringing a record of symptoms with dates and severities makes an…
-
New subcategory: rationale and scope Replied, post #119 · Meta › Announcements · 25 Oct 2025 · 21 likes Confirming post #118 from a second method, which matters more than confirming it from a second person. New subcategory is a good example of a question where the honest…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #42 · Compounds › Tirzepatide · 20 Oct 2025 · 9 likes On storage: published stability data covers the licensed formulation at its licensed concentration. A research preparation reconstituted at home in a different diluent…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #120 · Practice › Administration · 20 Oct 2025 · 10 likes Before the thread moves on from pinch — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #91 · Devices › Cold chain · 17 Oct 2025 · 27 likes Post #90 answers the question as asked. The question underneath it is different. Summer routes and winter routes are genuinely different problems, and a supplier that…
-
A preprint whose numbers changed substantially at publication Replied, post #55 · Evidence › Preprints · 16 Sep 2025 · 2 likes Version numbers on a preprint server matter. Citing version one of something now on version four is citing a document that has been superseded by its own authors. One…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #50 · Analytics › Method validation · 14 Sep 2025 · 9 likes Coming back to post #46, because the follow-up matters more than the original answer. My understanding of LOD and LOQ is a few years old and may have been superseded.…
-
Temperature loggers worth the money Replied, post #29 · Devices › Cold chain · 12 Sep 2025 · 0 likes A phase-change pack holds a defined temperature while it changes state and then behaves like anything else. A gel pack starts cold and warms continuously. They are…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #96 · Data & Tools › Datasets · 10 Sep 2025 · 12 likes Units in the column header, always, and the same units down the whole column. Mixed units in one field is the commonest defect in shared spreadsheets here. A guess,…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #75 · Data & Tools › Datasets · 9 Sep 2025 · 33 likes Units in the column header, always, and the same units down the whole column. Mixed units in one field is the commonest defect in shared spreadsheets here. I am aware…
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #18 · Practice › Reconstitution · 1 Sep 2025 · 2 likes Taking post #17 at face value and following it one step further. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #59 · Evidence › Journal club · 30 Aug 2025 · 10 likes That reframing is the whole thing. The facts I already had.
-
EU-wide position versus national implementation Replied, post #28 · Regional › European Union · 24 Aug 2025 · 26 likes EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #42 · Compounds › Retatrutide · 10 Aug 2025 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #10 · Evidence › Journal club · 10 Aug 2025 · 1 like The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
An emergency department visit, described afterwards Replied, post #52 · Safety › Adverse events · 10 Aug 2025 · 0 likes Signs of dehydration after repeated vomiting are the most common serious secondary problem described here and are also the most preventable. Written from notes rather…
-
A request that was declined, and the reasoning — a second dataset Replied, post #4 · Documentation › Wiki requests · 4 Aug 2025 · 0 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it. This is the sort of thing that ought to be settled and…
-
How to research a compound with no human data without deceiving yourself Replied, post #98 · Compounds › Other compounds · 4 Aug 2025 · 3 likes Post #95 is the version of this I will quote in future. One addition. A compound with no established assay is a compound where a certificate can say almost anything.…
-
How to research a compound with no human data without deceiving yourself Replied, post #87 · Compounds › Other compounds · 3 Aug 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #63 · Sourcing › Regulatory · 29 Jul 2025 · 4 likes Narrowing post #60, because the general version has more than one answer. The claim about compound being unapproved upthread is stronger than its source supports. I…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #40 · Devices › Syringes & needles · 27 Jul 2025 · 7 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 15 Jul 2025 · 2 likes The most useful reply I ever got about Reading a combination trial was a request to state my units. It sounds like pedantry and it has saved me twice.
-
System suitability injections: if they failed, the run did not happen Replied, post #14 · Analytics › HPLC & UHPLC · 13 Jul 2025 · 20 likes Building on post #12 rather than restating it. System suitability injections is one of those subjects where the general answer and the answer for a specific case…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #88 · Wellbeing › Mental health · 12 Jul 2025 · 0 likes Post #84 and I disagree about the size of the effect, not about the direction. Genuine question rather than a rhetorical one: has anyone here actually observed history…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #43 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 10 likes Two sentences on Nausea profile of amylin analogues and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #23 · Practice › Reconstitution · 10 Jul 2025 · 9 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I am aware…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #153 · Evidence › Journal club · 7 Jul 2025 · 20 likes Post #149 and I disagree about the size of the effect, not about the direction. Practical note on SURMOUNT-1: write down what you expect before you look. The number of…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #82 · Compounds › Tirzepatide · 4 Jul 2025 · 0 likes The arithmetic in post #81 is right; the assumption feeding it is the part to check. The five maintenance doses in the tirzepatide programme give a genuine…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #31 · Analytics › Mass spectrometry · 4 Jul 2025 · 0 likes Where I part company with post #29, and it is a narrow parting. Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #47 · Compounds › Repair & healing peptides · 22 Jun 2025 · 0 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #89 · Practice › Reconstitution · 22 Jun 2025 · 0 likes Post #87 put the caveat in the right place and I want to underline it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #46 · Regional › UK & Ireland · 17 Jun 2025 · 0 likes Confirming post #43 from a second method, which matters more than confirming it from a second person. Shortage positions have moved several times and any statement…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #10 · Compounds › Repair & healing peptides · 17 Jun 2025 · 13 likes The thing about BPC-157 that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
EU-wide position versus national implementation Replied, post #11 · Regional › European Union · 15 Jun 2025 · 13 likes Regional stock held inside the union removes a customs question entirely for intra-union movement, which is a practical difference rather than a legal opinion.
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #26 · Analytics › Mass spectrometry · 11 Jun 2025 · 8 likes Helpful, and short, which on this subject is harder than long.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #25 · Analytics › Home & field testing · 10 Jun 2025 · 0 likes Post #22 is the version of this I will quote in future. One addition. Quantitation has a well-known answer and a correct answer, and the interesting work is…
-
Washout: how long is long enough, and for what purpose Replied, post #30 · Pharmacology › Pharmacokinetics · 28 May 2025 · 6 likes This follows post #27 rather than contradicting it. What I would want before treating washout as settled: the method, the sample, and whether anyone tried to find the…
-
Half-life, steady state, and accumulation worked through Replied, post #26 · Pharmacology › Pharmacokinetics · 26 May 2025 · 21 likes Speaking only to half-life as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #37 · Compounds › Oral incretins · 25 May 2025 · 1 like The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #20 · Research Methods › N-of-1 designs · 19 May 2025 · 2 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
About the Body composition category Replied, post #6 · Outcomes › Body composition · 7 May 2025 · 26 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Antibiotics and a course of something with delayed emptying Replied, post #34 · Practice › Interactions · 4 May 2025 · 3 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Adjudicated events and why the definition matters — the long version Replied, post #119 · Evidence › Trials · 26 Apr 2025 · 0 likes The bit of Adjudicated events that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
-
Reading an MS report that only gives you a single number Replied, post #58 · Analytics › Mass spectrometry · 21 Apr 2025 · 0 likes Understood, and I withdraw the assumption I opened with.
-
A supplier that answers analytical questions with restated claims Replied, post #61 · Sourcing › Red flags · 20 Apr 2025 · 0 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Requesting a page: what makes a good request Replied, post #52 · Documentation › Wiki requests · 10 Apr 2025 · 32 likes A page that would need to be rewritten every quarter is usually better as a topic with a good marked solution. I looked this up rather than remembered it, which is the…
-
A certificate with no method stated: what can you conclude? Replied, post #44 · Analytics › COA interpretation · 8 Apr 2025 · 17 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 30 likes On dosing intervals: the long-acting design supports weekly administration, and the escalation schedules in the published trials are gentler than the compound's potency…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #5 · Evidence › Journal club · 17 Mar 2025 · 0 likes Building on post #2 rather than restating it. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand…
-
Maintainer handover: how it works Replied, post #53 · Meta › Wiki maintenance · 17 Mar 2025 · 32 likes The useful distinction on maintainer handover is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #107 · Pharmacology › Receptor biology · 16 Mar 2025 · 3 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
-
Assessing a warm arrival: the decision process Replied, post #14 · Sourcing › Logistics · 15 Mar 2025 · 1 like That is the distinction I keep failing to hold on to. Written down now.
-
Follow-up: What other technical communities get right that we do not Replied, post #39 · Lounge › Off topic · 14 Mar 2025 · 1 like Non-technical and offered in the right category: the best thing about a forum with no vote score is that the boring accurate answer sits at the same level as the…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #6 · Sourcing › Red flags · 9 Mar 2025 · 11 likes Counterpoint on certificate whose chromatogram axes, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #138 · Sourcing › Regulatory · 5 Mar 2025 · 0 likes Post-authorisation safety commitments are public and are one of the more useful sources for what a regulator considered uncertain at approval.
-
A promotion I argued against, and why I lost Replied, post #109 · Documentation › Doc review · 24 Feb 2025 · 0 likes Worth separating two things that post #106 runs together. Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to…
-
Validating a method you did not develop — does this still hold? Replied, post #28 · Analytics › Method validation · 20 Feb 2025 · 0 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
-
Reading an MS report that only gives you a single number Replied, post #14 · Analytics › Mass spectrometry · 20 Feb 2025 · 19 likes An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error.
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #6 · Clinical › Bloodwork · 18 Feb 2025 · 17 likes Post #5 answers the question as asked. The question underneath it is different. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #23 · Practice › Interactions · 13 Feb 2025 · 8 likes I would keep Anaesthesia and elective surgery and the decision it usually gets used for separate in this thread. They are related and they are not the same question,…
-
What we do not know about retatrutide, listed explicitly Replied, post #88 · Compounds › Retatrutide · 8 Feb 2025 · 13 likes Marking my place. If it changes for me I will come back and say so.
-
Protein density versus volume when you cannot eat much Replied, post #42 · Nutrition & Training › Protein & intake · 30 Jan 2025 · 2 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #91 · Compounds › Semaglutide · 24 Jan 2025 · 10 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
A page that has drifted out of date and needs a maintainer Replied, post #43 · Documentation › Wiki requests · 24 Dec 2024 · 3 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. The number is defensible. The precision I…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #15 · Practice › Interactions · 17 Dec 2024 · 0 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #13 · Practice › Dosing & titration · 3 Dec 2024 · 23 likes Understood, and I withdraw the assumption I opened with.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #64 · Compounds › Tirzepatide · 25 Nov 2024 · 4 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Fixed versus detachable needles: the trade-offs Replied, post #16 · Devices › Syringes & needles · 23 Nov 2024 · 5 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. On fixed versus detachable needles the community has more anecdote…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #30 · Sourcing › Regulatory · 16 Nov 2024 · 6 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. I would not lead a decision with…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #52 · Compounds › Repair & healing peptides · 14 Nov 2024 · 6 likes An observation about reading a preclinical wound-healing model that I cannot explain and am posting anyway, on the principle that unexplained observations are more…
-
Time to steady state after a dose increase Replied, post #133 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 1 like Thank you for taking the time. That was more work than a reply usually is.
-
Gallbladder disease risk with rapid weight loss Replied, post #11 · Clinical › Comorbidities · 20 Sep 2024 · 7 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. I read the earlier replies on gallbladder disease risk twice before writing this,…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #14 · Clinical › Bloodwork · 7 Sep 2024 · 3 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. Adding a source would improve this post and…
-
Correlation in a self-tracked dataset: what it can support Replied, post #56 · Research Methods › Statistics · 22 Aug 2024 · 0 likes Coming back to post #54, because the follow-up matters more than the original answer. Two things can be true about correlation at once: the mechanism is plausible and…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #20 · Analytics › COA interpretation · 9 Aug 2024 · 5 likes Where two documents for the same lot disagree, the useful question is which was measured and which was transcribed. Most such disagreements are the second. I would put…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #11 · Analytics › Method validation · 4 Aug 2024 · 2 likes Agreed on all of that, and I have nothing to add to it.
-
[2026 update] Request: show the solution author in the topic list Replied, post #3 · Meta › Feature requests · 1 Aug 2024 · 18 likes Answering the question the opening post raises rather than the one it answers. Use case: explain why you think the feature would help. "I would use this to..." makes…
-
Cold packs, phase-change material, and what survives ten days Replied, post #129 · Sourcing › Logistics · 21 Jul 2024 · 19 likes Cold packs would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #9 · Analytics › COA interpretation · 19 Jul 2024 · 25 likes Post #5 describes the usual case. This is about the unusual one. Adding what did not work for me on field-by-field walk through a certificate, since the failures never…
-
How this community labels and discusses unrefereed work Replied, post #97 · Evidence › Preprints · 19 Jul 2024 · 4 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. The part I am sure…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #4 · Compounds › Retatrutide · 15 Jul 2024 · 0 likes Post #2 is the version of this I will quote in future. One addition. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response…